Ser103
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser103  -  HDGF (rat)

Site Information
KASGYQSsQKKsCAE   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 18944905

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 1 ) , immunoassay ( 1 ) , immunoprecipitation ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
breast cancer ( 1 )
Relevant cell line - cell type - tissue:
COS7 (fibroblast) ( 1 ) , HEK293T (epithelial) ( 1 ) , MDA-MB-231 (breast cell) ( 1 ) , VSMC ('muscle, smooth') ( 1 )

Upstream Regulation
Treatments:
nocodazole ( 1 )

Downstream Regulation
Effects of modification on HDGF:
activity, induced ( 1 )
Effects of modification on biological processes:
cell cycle regulation ( 1 ) , cell growth, induced ( 1 )

References 

1

Everett AD, et al. (2011) Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen. BMC Cell Biol 12, 15
21489262   Curated Info